CN102665714A - 心房纤颤的治疗 - Google Patents

心房纤颤的治疗 Download PDF

Info

Publication number
CN102665714A
CN102665714A CN2010800519070A CN201080051907A CN102665714A CN 102665714 A CN102665714 A CN 102665714A CN 2010800519070 A CN2010800519070 A CN 2010800519070A CN 201080051907 A CN201080051907 A CN 201080051907A CN 102665714 A CN102665714 A CN 102665714A
Authority
CN
China
Prior art keywords
administration
sulfate
dose
infusion
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800519070A
Other languages
English (en)
Chinese (zh)
Inventor
加里·T·艾略特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica
Huya Bioscience International LLC
Original Assignee
Huya Bioscience International LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huya Bioscience International LLC filed Critical Huya Bioscience International LLC
Priority to CN201510364466.4A priority Critical patent/CN105362264A/zh
Publication of CN102665714A publication Critical patent/CN102665714A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CN2010800519070A 2009-11-17 2010-11-16 心房纤颤的治疗 Pending CN102665714A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510364466.4A CN105362264A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26192509P 2009-11-17 2009-11-17
US61/261,925 2009-11-17
PCT/US2010/056857 WO2011062906A2 (en) 2009-11-17 2010-11-16 Treatment of atrial fibrillation

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201410474946.1A Division CN104324024A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗
CN201510364466.4A Division CN105362264A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗

Publications (1)

Publication Number Publication Date
CN102665714A true CN102665714A (zh) 2012-09-12

Family

ID=44060290

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2010800519070A Pending CN102665714A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗
CN201410474946.1A Pending CN104324024A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗
CN201510364466.4A Pending CN105362264A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201410474946.1A Pending CN104324024A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗
CN201510364466.4A Pending CN105362264A (zh) 2009-11-17 2010-11-16 心房纤颤的治疗

Country Status (10)

Country Link
US (1) US8541464B2 (cg-RX-API-DMAC10.html)
EP (2) EP3311810B1 (cg-RX-API-DMAC10.html)
JP (2) JP6116908B2 (cg-RX-API-DMAC10.html)
CN (3) CN102665714A (cg-RX-API-DMAC10.html)
DK (2) DK3311810T3 (cg-RX-API-DMAC10.html)
ES (2) ES2644818T3 (cg-RX-API-DMAC10.html)
HU (2) HUE060876T2 (cg-RX-API-DMAC10.html)
PL (2) PL2501381T3 (cg-RX-API-DMAC10.html)
RS (1) RS63699B1 (cg-RX-API-DMAC10.html)
WO (1) WO2011062906A2 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112516136A (zh) * 2019-09-17 2021-03-19 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
SG2013035662A (en) 2013-05-08 2014-12-30 Menicon Singapore Pte Ltd Systems and methods for printing on a contact lens
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR102405199B1 (ko) * 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
US11813245B2 (en) * 2020-06-12 2023-11-14 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299813A (zh) * 1999-12-10 2001-06-20 中国科学院上海药物研究所 N－取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299813A (zh) * 1999-12-10 2001-06-20 中国科学院上海药物研究所 N－取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112516136A (zh) * 2019-09-17 2021-03-19 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用

Also Published As

Publication number Publication date
US8541464B2 (en) 2013-09-24
JP2013511473A (ja) 2013-04-04
JP6116908B2 (ja) 2017-04-19
EP3311810B1 (en) 2022-07-27
DK3311810T3 (da) 2022-10-24
WO2011062906A8 (en) 2012-02-09
CN105362264A (zh) 2016-03-02
HK1254495A1 (en) 2019-07-19
WO2011062906A9 (en) 2011-10-06
WO2011062906A2 (en) 2011-05-26
PL3311810T3 (pl) 2022-12-05
JP2016028054A (ja) 2016-02-25
ES2644818T3 (es) 2017-11-30
PL2501381T3 (pl) 2018-02-28
CN104324024A (zh) 2015-02-04
EP2501381A2 (en) 2012-09-26
EP2501381A4 (en) 2013-06-12
HUE034007T2 (en) 2018-01-29
RS63699B1 (sr) 2022-11-30
US20120309810A1 (en) 2012-12-06
HUE060876T2 (hu) 2023-04-28
EP3311810A1 (en) 2018-04-25
DK2501381T3 (da) 2017-11-06
EP2501381B1 (en) 2017-07-26
ES2929185T3 (es) 2022-11-25

Similar Documents

Publication Publication Date Title
CN104324024A (zh) 心房纤颤的治疗
US8188140B2 (en) Uses of ion channel modulating compounds
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
US20110166220A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
KR20160108611A (ko) 심방세동의 치료 방법
JP2013511473A5 (cg-RX-API-DMAC10.html)
JP6411215B2 (ja) 虚血傷害を治療するためのシステアミンおよび／またはシスタミン
JP2013511472A5 (cg-RX-API-DMAC10.html)
WO2009015561A1 (en) The use of leonurine and compositions thereof
CN116723836A (zh) 用于治疗急性心房颤动的舒欣啶施用
Frishman et al. Ultra-short-acting β-adrenergic blockers
RU2358732C2 (ru) Жидкие фармацевтические композиции, содержащие производные 3,7-диазабицикло(3,3,1)нонана, для лечения антиаритмических реакций
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
HK1176859A (en) Treatment of atrial fibrillation
HK1176859B (en) Treatment of atrial fibrillation
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
Gombotz et al. First clinical experience with the rapid-, short-acting amiodarone derivative E 047/1 after cardiac surgery
EP1868598A2 (en) A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
HK1176858B (en) Slow infusion of sulcardine and its salts
WO2008043211A1 (fr) Utilisation de la kétansérine pour la préparation de médicaments prévenant l'apoplexie cérébrale

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Elliot Gary T.

Inventor after: Bai Donglu

Inventor after: Wang Yiping

Inventor before: Elliot Gary T.

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20150910

Address after: American California

Applicant after: HUYA Bioscience International, LLC

Applicant after: Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Address before: American California

Applicant before: HUYA Bioscience International, LLC

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120912